nodes	percent_of_prediction	percent_of_DWPC	metapath
Glycine—SHMT1—Validated targets of C-MYC transcriptional activation—KIR3DL1—ankylosing spondylitis	0.0416	0.103	CbGpPWpGaD
Glycine—GLRA3—Ion channel transport—ANO6—ankylosing spondylitis	0.0379	0.094	CbGpPWpGaD
Glycine—GLRA2—Ion channel transport—ANO6—ankylosing spondylitis	0.0379	0.094	CbGpPWpGaD
Glycine—Blindness transient—Methotrexate—ankylosing spondylitis	0.0325	0.0787	CcSEcCtD
Glycine—GLRB—Ion channel transport—ANO6—ankylosing spondylitis	0.0309	0.0766	CbGpPWpGaD
Glycine—GLRA1—Ion channel transport—ANO6—ankylosing spondylitis	0.0244	0.0605	CbGpPWpGaD
Glycine—Electrolyte imbalance—Methylprednisolone—ankylosing spondylitis	0.0214	0.052	CcSEcCtD
Glycine—Electrolyte imbalance—Dexamethasone—ankylosing spondylitis	0.0195	0.0473	CcSEcCtD
Glycine—Electrolyte imbalance—Betamethasone—ankylosing spondylitis	0.0195	0.0473	CcSEcCtD
Glycine—SHMT2—Vitamin B12 Metabolism—CRP—ankylosing spondylitis	0.0173	0.0428	CbGpPWpGaD
Glycine—ALAS1—Budesonide—Methylprednisolone—ankylosing spondylitis	0.0159	0.0866	CbGdCrCtD
Glycine—ALAS1—Budesonide—Betamethasone—ankylosing spondylitis	0.0157	0.0853	CbGdCrCtD
Glycine—ALAS1—Budesonide—Dexamethasone—ankylosing spondylitis	0.0157	0.0853	CbGdCrCtD
Glycine—SLC6A5—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.0155	0.0385	CbGpPWpGaD
Glycine—SLC6A9—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.0155	0.0385	CbGpPWpGaD
Glycine—ALAS1—Budesonide—Triamcinolone—ankylosing spondylitis	0.0153	0.0833	CbGdCrCtD
Glycine—ALAS1—Budesonide—Prednisone—ankylosing spondylitis	0.0145	0.0791	CbGdCrCtD
Glycine—ALAS1—Budesonide—Prednisolone—ankylosing spondylitis	0.0142	0.0772	CbGdCrCtD
Glycine—SHMT2—Folate Metabolism—CRP—ankylosing spondylitis	0.0141	0.0348	CbGpPWpGaD
Glycine—GLRA3—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.0132	0.0327	CbGpPWpGaD
Glycine—GLRA2—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.0132	0.0327	CbGpPWpGaD
Glycine—SLC32A1—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.0132	0.0327	CbGpPWpGaD
Glycine—GLRB—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.0108	0.0267	CbGpPWpGaD
Glycine—ALAS1—Betamethasone—Methylprednisolone—ankylosing spondylitis	0.00974	0.053	CbGdCrCtD
Glycine—ALAS1—Dexamethasone—Methylprednisolone—ankylosing spondylitis	0.00974	0.053	CbGdCrCtD
Glycine—ALAS1—Betamethasone—Dexamethasone—ankylosing spondylitis	0.00959	0.0522	CbGdCrCtD
Glycine—ALAS1—Dexamethasone—Betamethasone—ankylosing spondylitis	0.00959	0.0522	CbGdCrCtD
Glycine—ALAS1—Dexamethasone—Triamcinolone—ankylosing spondylitis	0.00937	0.051	CbGdCrCtD
Glycine—ALAS1—Betamethasone—Triamcinolone—ankylosing spondylitis	0.00937	0.051	CbGdCrCtD
Glycine—Encephalopathy—Methotrexate—ankylosing spondylitis	0.00924	0.0224	CcSEcCtD
Glycine—ALAS1—Betamethasone—Prednisone—ankylosing spondylitis	0.00889	0.0484	CbGdCrCtD
Glycine—ALAS1—Dexamethasone—Prednisone—ankylosing spondylitis	0.00889	0.0484	CbGdCrCtD
Glycine—ALAS1—Betamethasone—Prednisolone—ankylosing spondylitis	0.00868	0.0472	CbGdCrCtD
Glycine—ALAS1—Dexamethasone—Prednisolone—ankylosing spondylitis	0.00868	0.0472	CbGdCrCtD
Glycine—GLRA1—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.00851	0.0211	CbGpPWpGaD
Glycine—GPR18—GPCRs, Class A Rhodopsin-like—PTGER4—ankylosing spondylitis	0.00839	0.0208	CbGpPWpGaD
Glycine—Lung disorder—Methotrexate—ankylosing spondylitis	0.00838	0.0203	CcSEcCtD
Glycine—SHMT1—Folate Metabolism—CRP—ankylosing spondylitis	0.00829	0.0205	CbGpPWpGaD
Glycine—Thrombophlebitis—Prednisolone—ankylosing spondylitis	0.00819	0.0198	CcSEcCtD
Glycine—SHMT2—Vitamin B12 Metabolism—TNF—ankylosing spondylitis	0.00782	0.0194	CbGpPWpGaD
Glycine—SLC36A1—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.00758	0.0188	CbGpPWpGaD
Glycine—Thrombophlebitis—Triamcinolone—ankylosing spondylitis	0.00753	0.0183	CcSEcCtD
Glycine—Thrombophlebitis—Methylprednisolone—ankylosing spondylitis	0.00751	0.0182	CcSEcCtD
Glycine—Visual disturbance—Prednisolone—ankylosing spondylitis	0.00748	0.0181	CcSEcCtD
Glycine—GPR18—Class A/1 (Rhodopsin-like receptors)—PTGER4—ankylosing spondylitis	0.00719	0.0178	CbGpPWpGaD
Glycine—Thrombophlebitis—Dexamethasone—ankylosing spondylitis	0.00683	0.0166	CcSEcCtD
Glycine—Thrombophlebitis—Betamethasone—ankylosing spondylitis	0.00683	0.0166	CcSEcCtD
Glycine—SHMT2—Folate Metabolism—TNF—ankylosing spondylitis	0.00637	0.0158	CbGpPWpGaD
Glycine—Visual disturbance—Dexamethasone—ankylosing spondylitis	0.00624	0.0151	CcSEcCtD
Glycine—Visual disturbance—Betamethasone—ankylosing spondylitis	0.00624	0.0151	CcSEcCtD
Glycine—Thrombophlebitis—Prednisone—ankylosing spondylitis	0.00595	0.0144	CcSEcCtD
Glycine—GPR18—GPCR ligand binding—PTGER4—ankylosing spondylitis	0.00548	0.0136	CbGpPWpGaD
Glycine—Coma—Methotrexate—ankylosing spondylitis	0.00542	0.0131	CcSEcCtD
Glycine—Thrombophlebitis—Methotrexate—ankylosing spondylitis	0.00497	0.0121	CcSEcCtD
Glycine—Polyuria—Methotrexate—ankylosing spondylitis	0.0049	0.0119	CcSEcCtD
Glycine—Visual impairment—Prednisolone—ankylosing spondylitis	0.00473	0.0115	CcSEcCtD
Glycine—SLC16A10—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.00461	0.0114	CbGpPWpGaD
Glycine—Visual disturbance—Methotrexate—ankylosing spondylitis	0.00454	0.011	CcSEcCtD
Glycine—Rhinitis—Triamcinolone—ankylosing spondylitis	0.00452	0.011	CcSEcCtD
Glycine—Rhinitis—Methylprednisolone—ankylosing spondylitis	0.00451	0.0109	CcSEcCtD
Glycine—Visual impairment—Methylprednisolone—ankylosing spondylitis	0.00434	0.0105	CcSEcCtD
Glycine—Vision blurred—Prednisolone—ankylosing spondylitis	0.00402	0.00975	CcSEcCtD
Glycine—Visual impairment—Dexamethasone—ankylosing spondylitis	0.00394	0.00956	CcSEcCtD
Glycine—Visual impairment—Betamethasone—ankylosing spondylitis	0.00394	0.00956	CcSEcCtD
Glycine—Vertigo—Prednisolone—ankylosing spondylitis	0.00383	0.0093	CcSEcCtD
Glycine—ALAS2—Metabolism—B3GNT2—ankylosing spondylitis	0.00382	0.00946	CbGpPWpGaD
Glycine—Back pain—Triamcinolone—ankylosing spondylitis	0.0038	0.0092	CcSEcCtD
Glycine—SHMT1—Folate Metabolism—TNF—ankylosing spondylitis	0.00375	0.00929	CbGpPWpGaD
Glycine—Convulsion—Prednisolone—ankylosing spondylitis	0.0037	0.00896	CcSEcCtD
Glycine—Vertigo—Triamcinolone—ankylosing spondylitis	0.00353	0.00855	CcSEcCtD
Glycine—Vertigo—Methylprednisolone—ankylosing spondylitis	0.00352	0.00853	CcSEcCtD
Glycine—Oedema—Prednisolone—ankylosing spondylitis	0.00348	0.00844	CcSEcCtD
Glycine—SHMT1—Disease—ANTXR2—ankylosing spondylitis	0.00346	0.00856	CbGpPWpGaD
Glycine—Convulsion—Triamcinolone—ankylosing spondylitis	0.0034	0.00824	CcSEcCtD
Glycine—Tachycardia—Prednisolone—ankylosing spondylitis	0.0034	0.00824	CcSEcCtD
Glycine—Convulsion—Methylprednisolone—ankylosing spondylitis	0.00339	0.00823	CcSEcCtD
Glycine—Oedema—Triamcinolone—ankylosing spondylitis	0.0032	0.00777	CcSEcCtD
Glycine—Vertigo—Dexamethasone—ankylosing spondylitis	0.0032	0.00776	CcSEcCtD
Glycine—Vertigo—Betamethasone—ankylosing spondylitis	0.0032	0.00776	CcSEcCtD
Glycine—Tachycardia—Triamcinolone—ankylosing spondylitis	0.00313	0.00758	CcSEcCtD
Glycine—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.00312	0.00756	CcSEcCtD
Glycine—GPR18—GPCR downstream signaling—PTGER4—ankylosing spondylitis	0.00309	0.00767	CbGpPWpGaD
Glycine—Convulsion—Dexamethasone—ankylosing spondylitis	0.00309	0.00748	CcSEcCtD
Glycine—Convulsion—Betamethasone—ankylosing spondylitis	0.00309	0.00748	CcSEcCtD
Glycine—Hypotension—Methylprednisolone—ankylosing spondylitis	0.00299	0.00724	CcSEcCtD
Glycine—Pain—Prednisolone—ankylosing spondylitis	0.00298	0.00722	CcSEcCtD
Glycine—Vision blurred—Prednisone—ankylosing spondylitis	0.00292	0.00709	CcSEcCtD
Glycine—Oedema—Dexamethasone—ankylosing spondylitis	0.00291	0.00705	CcSEcCtD
Glycine—Oedema—Betamethasone—ankylosing spondylitis	0.00291	0.00705	CcSEcCtD
Glycine—GLYAT—Metabolism—B3GNT2—ankylosing spondylitis	0.00289	0.00717	CbGpPWpGaD
Glycine—GATM—Metabolism—B3GNT2—ankylosing spondylitis	0.00289	0.00717	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—B3GNT2—ankylosing spondylitis	0.00289	0.00717	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—B3GNT2—ankylosing spondylitis	0.00289	0.00717	CbGpPWpGaD
Glycine—Visual impairment—Methotrexate—ankylosing spondylitis	0.00287	0.00696	CcSEcCtD
Glycine—Tachycardia—Betamethasone—ankylosing spondylitis	0.00284	0.00688	CcSEcCtD
Glycine—Tachycardia—Dexamethasone—ankylosing spondylitis	0.00284	0.00688	CcSEcCtD
Glycine—GPR18—Signaling by GPCR—PTGER4—ankylosing spondylitis	0.00281	0.00696	CbGpPWpGaD
Glycine—Vertigo—Prednisone—ankylosing spondylitis	0.00279	0.00675	CcSEcCtD
Glycine—Urticaria—Prednisolone—ankylosing spondylitis	0.00277	0.00671	CcSEcCtD
Glycine—BAAT—Metabolism—B3GNT2—ankylosing spondylitis	0.00276	0.00684	CbGpPWpGaD
Glycine—Pain—Triamcinolone—ankylosing spondylitis	0.00274	0.00664	CcSEcCtD
Glycine—Hypotension—Dexamethasone—ankylosing spondylitis	0.00272	0.00658	CcSEcCtD
Glycine—Hypotension—Betamethasone—ankylosing spondylitis	0.00272	0.00658	CcSEcCtD
Glycine—Convulsion—Prednisone—ankylosing spondylitis	0.00269	0.00651	CcSEcCtD
Glycine—Chills—Methotrexate—ankylosing spondylitis	0.00267	0.00648	CcSEcCtD
Glycine—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.00257	0.00622	CcSEcCtD
Glycine—GRIN2C—Alzheimers Disease—TNF—ankylosing spondylitis	0.00255	0.00632	CbGpPWpGaD
Glycine—Urticaria—Triamcinolone—ankylosing spondylitis	0.00254	0.00617	CcSEcCtD
Glycine—Urticaria—Methylprednisolone—ankylosing spondylitis	0.00254	0.00616	CcSEcCtD
Glycine—Oedema—Prednisone—ankylosing spondylitis	0.00253	0.00614	CcSEcCtD
Glycine—Back pain—Methotrexate—ankylosing spondylitis	0.00251	0.00608	CcSEcCtD
Glycine—Pain—Betamethasone—ankylosing spondylitis	0.00249	0.00603	CcSEcCtD
Glycine—Pain—Dexamethasone—ankylosing spondylitis	0.00249	0.00603	CcSEcCtD
Glycine—Tachycardia—Prednisone—ankylosing spondylitis	0.00247	0.00599	CcSEcCtD
Glycine—AGXT—Metabolism—B3GNT2—ankylosing spondylitis	0.00246	0.0061	CbGpPWpGaD
Glycine—Vision blurred—Methotrexate—ankylosing spondylitis	0.00244	0.00592	CcSEcCtD
Glycine—ALAS1—Metabolism—B3GNT2—ankylosing spondylitis	0.00238	0.00591	CbGpPWpGaD
Glycine—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.00236	0.00572	CcSEcCtD
Glycine—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.00235	0.00571	CcSEcCtD
Glycine—Vertigo—Methotrexate—ankylosing spondylitis	0.00233	0.00565	CcSEcCtD
Glycine—Urticaria—Dexamethasone—ankylosing spondylitis	0.00231	0.0056	CcSEcCtD
Glycine—Urticaria—Betamethasone—ankylosing spondylitis	0.00231	0.0056	CcSEcCtD
Glycine—Dizziness—Prednisolone—ankylosing spondylitis	0.0023	0.00558	CcSEcCtD
Glycine—Convulsion—Methotrexate—ankylosing spondylitis	0.00225	0.00544	CcSEcCtD
Glycine—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.00219	0.0053	CcSEcCtD
Glycine—Dizziness—Triamcinolone—ankylosing spondylitis	0.00212	0.00513	CcSEcCtD
Glycine—Dizziness—Methylprednisolone—ankylosing spondylitis	0.00211	0.00512	CcSEcCtD
Glycine—AGXT2—Metabolism—B3GNT2—ankylosing spondylitis	0.00209	0.00518	CbGpPWpGaD
Glycine—Nausea—Prednisolone—ankylosing spondylitis	0.00207	0.00502	CcSEcCtD
Glycine—SHMT1—Disease—B3GNT2—ankylosing spondylitis	0.00204	0.00505	CbGpPWpGaD
Glycine—Vomiting—Triamcinolone—ankylosing spondylitis	0.00204	0.00494	CcSEcCtD
Glycine—Vomiting—Methylprednisolone—ankylosing spondylitis	0.00203	0.00493	CcSEcCtD
Glycine—Urticaria—Prednisone—ankylosing spondylitis	0.00201	0.00487	CcSEcCtD
Glycine—GPR18—Signaling by GPCR—MMP3—ankylosing spondylitis	0.002	0.00496	CbGpPWpGaD
Glycine—Diarrhoea—Betamethasone—ankylosing spondylitis	0.00199	0.00482	CcSEcCtD
Glycine—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.00199	0.00482	CcSEcCtD
Glycine—Hypotension—Methotrexate—ankylosing spondylitis	0.00198	0.00479	CcSEcCtD
Glycine—GRIN2A—Alzheimers Disease—TNF—ankylosing spondylitis	0.00195	0.00482	CbGpPWpGaD
Glycine—Dizziness—Dexamethasone—ankylosing spondylitis	0.00192	0.00466	CcSEcCtD
Glycine—Dizziness—Betamethasone—ankylosing spondylitis	0.00192	0.00466	CcSEcCtD
Glycine—Nausea—Triamcinolone—ankylosing spondylitis	0.0019	0.00461	CcSEcCtD
Glycine—Nausea—Methylprednisolone—ankylosing spondylitis	0.0019	0.0046	CcSEcCtD
Glycine—Hypersensitivity—Prednisone—ankylosing spondylitis	0.00187	0.00452	CcSEcCtD
Glycine—Vomiting—Betamethasone—ankylosing spondylitis	0.00185	0.00448	CcSEcCtD
Glycine—Vomiting—Dexamethasone—ankylosing spondylitis	0.00185	0.00448	CcSEcCtD
Glycine—Pain—Methotrexate—ankylosing spondylitis	0.00181	0.00439	CcSEcCtD
Glycine—Diarrhoea—Prednisone—ankylosing spondylitis	0.00173	0.0042	CcSEcCtD
Glycine—Nausea—Dexamethasone—ankylosing spondylitis	0.00173	0.00419	CcSEcCtD
Glycine—Nausea—Betamethasone—ankylosing spondylitis	0.00173	0.00419	CcSEcCtD
Glycine—SHMT1—Metabolism—B3GNT2—ankylosing spondylitis	0.00171	0.00423	CbGpPWpGaD
Glycine—Urticaria—Methotrexate—ankylosing spondylitis	0.00168	0.00407	CcSEcCtD
Glycine—Dizziness—Prednisone—ankylosing spondylitis	0.00167	0.00406	CcSEcCtD
Glycine—GSS—Metabolism—B3GNT2—ankylosing spondylitis	0.00166	0.00412	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—PTGER4—ankylosing spondylitis	0.00166	0.00411	CbGpPWpGaD
Glycine—Vomiting—Prednisone—ankylosing spondylitis	0.00161	0.0039	CcSEcCtD
Glycine—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.00156	0.00378	CcSEcCtD
Glycine—Nausea—Prednisone—ankylosing spondylitis	0.0015	0.00364	CcSEcCtD
Glycine—Diarrhoea—Methotrexate—ankylosing spondylitis	0.00145	0.00351	CcSEcCtD
Glycine—Dizziness—Methotrexate—ankylosing spondylitis	0.0014	0.00339	CcSEcCtD
Glycine—Vomiting—Methotrexate—ankylosing spondylitis	0.00135	0.00326	CcSEcCtD
Glycine—Nausea—Methotrexate—ankylosing spondylitis	0.00126	0.00305	CcSEcCtD
Glycine—GPR18—Signaling Pathways—MMP3—ankylosing spondylitis	0.00118	0.00293	CbGpPWpGaD
Glycine—SHMT1—Disease—HLA-A—ankylosing spondylitis	0.000824	0.00204	CbGpPWpGaD
